Bausch Health Companies Inc.

By person

42 insiders · 97 transactions

13.1×

Thomas J. Appio holds 13.1 times base salary in stock. $16.28M of shares against $1.24M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas J. Appio last reported holding, valued at $7.03, the price Common Shares, No Par Value was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Paulson John

Director

$566.66M (22)

$113.78M (2)

+$452.88M

97,025,146

25.94%

$682.09M

+101.0%

Pershing Square Capital Management, L.P. entity

See footnote (3)

—

$250.89M (2)

−$250.89M

0.0000%

$0.00

−100.0%

ValueAct Holdings, L.P. entity

Director

$50.71M (3)

$18.25M (1)

+$32.47M

17,931,594

4.79%

$126.06M

+19.2%

PAULSON & CO. INC. entity

10% owner

$15.63M (1)

—

+$15.63M

73,255,869

19.59%

$514.99M

+3.5%

DE SCHUTTER RICHARD U

Director

$4.80M (12)

—

+$4.80M

387,207

0.1035%

$2.72M

+10,668%

ACKERMANN CHRISTINA

EVP AND GENERAL COUNSEL

$80.11K (1)

$4.53M (5) scheduled

−$4.45M

162,240

0.0434%

$1.14M

+172.3%

PAPA JOSEPH C

Director

$2.56M (4)

—

+$2.56M

1,427,568

0.3817%

$10.04M

+148.1%

Humphries William D.

President, Ortho-Dermatologics

$650.14K (1)

$3.08M (5) scheduled

−$2.43M

235,035

0.0628%

$1.65M

—

Miller Steven D

Director

$1.45M (2)

—

+$1.45M

239,224

0.0640%

$1.68M

+239,124%

Herendeen Paul

EVP and CFO

$724.85K (3)

—

+$724.85K

386,618

0.1034%

$2.72M

+157.7%

APPIO THOMAS

Chief Executive Officer

$584.02K (1)

—

+$584.02K

2,315,374

0.6191%

$16.28M

+10,765%

Eldessouky Sam

EVP & Chief Financial Officer

—

$538.59K (1)

−$538.59K

119,455

0.0319%

$839.77K

+122.1%

Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

—

$494.47K (3)

−$494.47K

93,139

0.0249%

$654.77K

+130.6%

Carson Seana

EVP, General Counsel

—

$421.37K (14) scheduled

−$421.37K

616,761

0.1649%

$4.34M

+799.5%

WECHSLER AMY B

Director

—

$350.81K (1)

−$350.81K

314,979

0.0842%

$2.21M

+1,804%

Spurr Robert

President, U.S. Businesses

—

$348.16K (5)

−$348.16K

112,741

0.0301%

$792.57K

+180.1%

Lenar Aimee J.

President, US Pharma

—

$258.89K (1) scheduled

−$258.89K

334,853

0.0895%

$2.35M

—

Lee Frank D.

Director

—

$254.68K (2) scheduled

−$254.68K

95,210

0.0255%

$669.33K

—

McKenna Mark C.

President, Salix

—

$235.22K (1)

−$235.22K

20,756

0.0055%

$145.91K

−1.8%

Ross Thomas W. Sr.

Director

$112.49K (2)

—

+$112.49K

161,516

0.0432%

$1.14M

+654.1%

VON ESCHENBACH ANDREW C.

Director

$56.31K (2)

—

+$56.31K

38,647

0.0103%

$271.69K

+3,765%

Hale David Robert

Director

—

18,908,638

5.06%

$132.93M

+0.3%

Charhon Jean-Jacques

EVP, CFO

—

706,478

0.1889%

$4.97M

—

Kellen Ari

EVP, Company Group Chairman

—

630,842

0.1687%

$4.43M

−3.1%

Vadaketh Tom George

EVP, Chief Financial Officer

—

564,933

0.1511%

$3.97M

+455.9%

Rosiello Robert L.

EVP, Corp Dev & Strategy

—

517,683

0.1384%

$3.64M

−2.9%

POWER ROBERT N

Director

—

300,594

0.0804%

$2.11M

+827.2%

KAVANAGH SARAH B

Director

—

282,230

0.0755%

$1.98M

+1,908%

ROBERTSON RUSSEL C

Director

—

225,279

0.0602%

$1.58M

+1,322%

ICAHN BRETT

Director

—

220,280

0.0589%

$1.55M

—

Barresi John S

SVP, Controller & CAO

—

192,268

0.0514%

$1.35M

—

Whitaker Anne Clem

EVP, Company Group Chairman

—

158,885

0.0425%

$1.12M

−3.9%

Mulligan Richard

Director

—

155,616

0.0416%

$1.09M

+340.1%

Garcia Christian A

Director

—

135,578

0.0363%

$953.11K

—

KARABELAS ARGERIS N

Director

—

123,715

0.0331%

$869.72K

+508.8%

LEUNG SANDRA

Director

—

97,070

0.0260%

$682.40K

—

INGRAM ROBERT ALEXANDER

Director

—

92,046

0.0246%

$647.08K

+5.1%

GOETTLER MICHAEL

Director

—

76,020

0.0203%

$534.42K

—

LEE STEVEN HYOSIG

SVP, Controller & CAO

—

70,114

0.0187%

$492.90K

—

ROBERTS EIRY

Director

—

45,871

0.0123%

$322.47K

—

ESHELMAN FREDRIC N

Director

—

38,298

0.0102%

$269.23K

+115.2%

Munsch Frederick

SVP, Controller and CAO

—

22,435

0.0060%

$157.72K

+6.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Lee Frank D.

21 Aug 2025

Director

Sell

15,912

$7.66

$121.89K

Carson Seana

28 Feb 2023

EVP, General Counsel

Sell

292

$9.32

$2.72K

Spurr Robert

14 Apr 2022

U.S. President-Pharma Business

Sell

1,595

$22.19

$35.39K

Spurr Robert

15 Mar 2022

U.S. President-Pharma Business

Sell

4,846

$22.20

$107.58K

Gordon Joseph F

8 Mar 2022

Pres&Co-Head Bausch&Lomb/Int'l

Sell

3,889

$21.76

$84.62K

Spurr Robert

2 Mar 2022

U.S. President-Pharma Business

Sell

1,595

$23.37

$37.28K

Gordon Joseph F

2 Mar 2022

Pres&Co-Head Bausch&Lomb/Int'l

Sell

11,077

$23.37

$258.87K

Gordon Joseph F

1 Mar 2022

Pres&Co-Head Bausch&Lomb/Int'l

Sell

6,338

$23.82

$150.97K

Spurr Robert

15 Feb 2022

U.S. President-Pharma Business

Sell

3,251

$25.02

$81.34K

Spurr Robert

18 Jan 2022

U.S. President-Pharma Business

Sell

3,251

$26.63

$86.57K

Eldessouky Sam

11 Jun 2021

EVP & Chief Financial Officer

Sell

17,000

$31.68

$538.59K

WECHSLER AMY B

26 May 2021

Director

Sell

11,037

$31.79

$350.81K

Humphries William D.

8 Sep 2020

President, Ortho-Dermatologics

Sell

5,667

$16.17

$91.64K

ValueAct Holdings, L.P.

5 Jun 2020

Director

Sell indirect

948,353

$19.24

$18.25M

McKenna Mark C.

19 Aug 2019

President, Salix

Sell

10,773

$21.83

$235.22K

ACKERMANN CHRISTINA

12 Aug 2019

EVP AND GENERAL COUNSEL

Sell

3,418

$22.45

$76.73K

ACKERMANN CHRISTINA

11 Jul 2019

EVP AND GENERAL COUNSEL

Sell

3,968

$24.81

$98.45K

ACKERMANN CHRISTINA

16 Oct 2018

EVP AND GENERAL COUNSEL

Sell

4,542

$25.50

$115.82K

ACKERMANN CHRISTINA

15 Oct 2018

EVP AND GENERAL COUNSEL

Sell

15,404

$24.83

$382.48K

Paulson John

6 Mar 2018

Director

Sell indirect

7,066,629

$15.40

$108.83M

Paulson John

16 Nov 2017

Director

Sell indirect

344,216

$14.39

$4.95M

Pershing Square Capital Management, L.P.

13 Mar 2017

Director

Sell indirect

18,114,432

$11.00

$199.26M

Pershing Square Capital Management, L.P.

12 Dec 2016

Director

Sell indirect

3,476,690

$14.85

$51.63M

Show all 97 transactions →

Bausch Health Companies Inc.

By person

Individual transactions

What was left out